A detailed history of Stonebridge Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Stonebridge Financial Group, LLC holds 33,182 shares of ABT stock, worth $4.23 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
33,182
Previous 33,565 1.14%
Holding current value
$4.23 Million
Previous $4.57 Billion 2.64%
% of portfolio
0.39%
Previous 0.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

SELL
$120.51 - $136.62 $46,155 - $52,325
-383 Reduced 1.14%
33,182 $4.44 Billion
Q2 2025

Jul 24, 2025

SELL
$123.95 - $138.08 $129,651 - $144,431
-1,046 Reduced 3.02%
33,565 $4.57 Billion
Q1 2025

Apr 25, 2025

BUY
$111.1 - $140.22 $4,555 - $5,749
41 Added 0.12%
34,611 $4.59 Billion
Q4 2024

Jan 29, 2025

BUY
$111.93 - $119.39 $3.87 Million - $4.13 Million
34,570 New
34,570 $3.91 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $223B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Stonebridge Financial Group, LLC Portfolio

Follow Stonebridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Financial Group, LLC with notifications on news.